There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease #osteoarthritis NEW Data drop at #ADA2023: Retatrutide, a triple agonist (GLP1, GIP, glucagon) lost an incredible 24.2% of their body weight, which amounts to 58 lbs
Heres a way to look at whats next: Short-Term Approach: A Starting Point Some individuals rely on GLP-1 for 3 to 12 months to achieve goals like: Break cycles of food addiction
Evernorth EnReachRx and Evernorth EnGuide SM Pharmacy can help make this next step easier, providing dependable access to many FDA-approved GLP-1 medications, convenient 90-day home delivery and a clinical care model built around you, with specially trained pharmacists, proactive monitoring and the tools to help you stay on track
Although it's still in clinical trials and not yet FDA approved, its trial results are highly promising
Trusted by 15,000+ Researchers Consistent purity
Read our full Research Use Disclaimer